| Primary |
| Hiv Infection |
64.4% |
| Hepatitis B |
12.7% |
| Product Used For Unknown Indication |
5.3% |
| Hypertension |
2.0% |
| Acquired Immunodeficiency Syndrome |
1.7% |
| Prophylaxis |
1.4% |
| Tuberculosis |
1.4% |
| Prophylaxis Against Hiv Infection |
1.4% |
| Diabetes Mellitus |
1.2% |
| Drug Use For Unknown Indication |
1.2% |
| Antiretroviral Therapy |
1.1% |
| Depression |
1.0% |
| Pain |
0.9% |
| Drug Exposure During Pregnancy |
0.8% |
| Chronic Hepatitis B |
0.8% |
| Antifungal Prophylaxis |
0.7% |
| Antibiotic Prophylaxis |
0.6% |
| Liver Transplant |
0.5% |
| Hiv Test Positive |
0.5% |
| Hepatitis B Virus |
0.4% |
|
| Abortion Spontaneous |
13.1% |
| Renal Failure Acute |
10.1% |
| Renal Failure |
9.7% |
| Vomiting |
6.5% |
| Death |
5.4% |
| Renal Tubular Disorder |
5.4% |
| Osteoporosis |
5.3% |
| Pregnancy |
5.3% |
| Stillbirth |
5.3% |
| Weight Decreased |
4.6% |
| Viral Load Increased |
3.7% |
| Ultrasound Antenatal Screen Abnormal |
3.5% |
| Blood Creatinine Increased |
3.2% |
| Rhabdomyolysis |
3.0% |
| Osteonecrosis |
2.9% |
| Renal Tubular Acidosis |
2.9% |
| Fanconi Syndrome Acquired |
2.6% |
| Proteinuria |
2.6% |
| Thrombocytopenia |
2.6% |
| Therapeutic Response Decreased |
2.4% |
|
| Secondary |
| Hiv Infection |
60.2% |
| Drug Use For Unknown Indication |
6.7% |
| Antiretroviral Therapy |
5.0% |
| Product Used For Unknown Indication |
4.9% |
| Acquired Immunodeficiency Syndrome |
4.7% |
| Drug Exposure During Pregnancy |
3.7% |
| Antiviral Treatment |
3.7% |
| Hepatitis B |
2.7% |
| Hypertension |
1.1% |
| Pain |
0.9% |
| Hepatitis C |
0.9% |
| Tuberculosis |
0.9% |
| Hiv Test Positive |
0.7% |
| Trigeminal Neuralgia |
0.7% |
| Diabetes Mellitus |
0.7% |
| Insomnia |
0.7% |
| Prophylaxis |
0.6% |
| Maternal Exposure During Pregnancy |
0.5% |
| Haemophilia |
0.4% |
| Maternal Exposure Timing Unspecified |
0.4% |
|
| Drug Exposure During Pregnancy |
16.6% |
| Vomiting |
10.9% |
| Renal Failure |
7.0% |
| Abortion Spontaneous |
6.1% |
| Weight Decreased |
5.8% |
| Renal Failure Acute |
5.6% |
| Thrombocytopenia |
5.3% |
| Renal Impairment |
5.1% |
| Stillbirth |
4.9% |
| Pregnancy |
4.0% |
| Renal Tubular Disorder |
3.5% |
| Diabetes Mellitus |
3.3% |
| Myositis |
3.0% |
| Umbilical Cord Abnormality |
3.0% |
| Polydactyly |
2.8% |
| Premature Baby |
2.8% |
| Renal Disorder |
2.8% |
| Osteoporosis |
2.6% |
| Lymphadenopathy |
2.5% |
| Optic Neuritis Retrobulbar |
2.5% |
|
| Concomitant |
| Hiv Infection |
62.0% |
| Drug Use For Unknown Indication |
8.4% |
| Product Used For Unknown Indication |
3.4% |
| Medical Diet |
3.0% |
| Acquired Immunodeficiency Syndrome |
2.6% |
| Depression |
2.3% |
| Prophylaxis |
2.2% |
| Hepatitis C |
2.1% |
| Hypertension |
2.1% |
| Antiretroviral Therapy |
1.9% |
| Antibiotic Prophylaxis |
1.6% |
| Diarrhoea |
1.3% |
| Retroviral Infection |
1.1% |
| Antifungal Prophylaxis |
1.1% |
| Mineral Supplementation |
1.0% |
| Back Pain |
1.0% |
| Hepatitis B |
0.9% |
| Diabetes Mellitus |
0.8% |
| Mycobacterium Avium Complex Infection |
0.7% |
| Vitamin Supplementation |
0.7% |
|
| Vomiting |
16.0% |
| Weight Decreased |
8.1% |
| Pyrexia |
6.9% |
| Death |
6.2% |
| Contusion |
6.0% |
| Renal Failure |
5.5% |
| Rash Maculo-papular |
5.0% |
| Myocardial Infarction |
4.5% |
| Osteonecrosis |
4.3% |
| Nausea |
4.1% |
| Rash |
4.1% |
| Renal Failure Acute |
4.1% |
| Thrombocytopenia |
3.6% |
| Pancytopenia |
3.3% |
| Varices Oesophageal |
3.3% |
| Stillbirth |
3.1% |
| Weight Increased |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
| Blood Lactic Acid Increased |
2.9% |
| Pneumonia |
2.9% |
|
| Interacting |
| Hiv Infection |
44.3% |
| Infection |
29.0% |
| Product Used For Unknown Indication |
12.2% |
| Drug Use For Unknown Indication |
3.6% |
| Hepatitis B |
1.4% |
| Smoking Cessation Therapy |
1.4% |
| Blood Pressure Increased |
0.9% |
| Hypertension |
0.9% |
| Liver Transplant |
0.9% |
| Myocardial Ischaemia |
0.9% |
| Tobacco Abuse |
0.9% |
| Arthralgia |
0.5% |
| Drug Dependence |
0.5% |
| Gastritis Prophylaxis |
0.5% |
| Hepatic Cirrhosis |
0.5% |
| Nephropathy |
0.5% |
| Pain In Extremity |
0.5% |
| Pneumocystis Jiroveci Infection |
0.5% |
| Type 2 Diabetes Mellitus |
0.5% |
|
| Renal Failure Chronic |
29.6% |
| Drug Interaction |
14.8% |
| Weight Increased |
11.1% |
| Somnolence |
7.4% |
| Abdominal Pain |
3.7% |
| Fanconi Syndrome |
3.7% |
| Megacolon |
3.7% |
| Pancreatitis |
3.7% |
| Potentiating Drug Interaction |
3.7% |
| Renal Failure |
3.7% |
| Renal Impairment |
3.7% |
| Renal Tubular Acidosis |
3.7% |
| Sedation |
3.7% |
| Vomiting |
3.7% |
|
